For HTBX, the risks are especially profound. One of the main caveats (and this will be the case with most of the rest of these picks) is the inherent riskiness of micro-cap stocks. Unlike other exotic pharmaceutical solutions, this is using nature to protect nature. Essentially, this biotechnology transforms cancer cells into a naturally occurring protein called “gp96.”Īccording to HTBX, “gp96 is a “ molecular warning system” that has evolved important properties as a natural defense against necrotic cell death, in order to serve as a sentinel to alert our immune systems to the presence and identity of dangerous pathogens.” By inducing this protein’s production, the HTBX therapy allows for a multi-pronged attack against malignant cells. Rather than reinventing the wheel in terms of cancer treatment, why not enhance what is already available? This led to the creation of the Immune Pan-Antigen Cytotoxic Therapy, or “ImPACT” for short. Source: Source: JYE Financial, unless otherwise indicated Many of these investments still entail enormous risks, but if you’re looking for somewhere to put the speculative funds in your portfolio for 2017, you could do worse than these 10 micro-cap stocks to buy: But a few smaller companies actually trade on real exchanges and have honest-to-god legitimate financial results - so you at least have a better measure of what they are and the direction they’re heading. Of course, most micro-cap stocks - especially those that trade over the counter - are complete garbage, existing only because morally rudderless attorneys were willing to legitimize a fly-by-night operation. Technology, media and even defense - there are smaller companies trying to break through just about everywhere.
While many investors think nothing of investing in small-cap and micro-cap biotech companies, there are plenty of high-growth opportunities outside the medical arena. But as soon as anything upsets the supply chain, disaster is only a mouse click away. Or they might be the specialty parts supplier to a larger client. So long as business is good, micro-cap stocks can soar to the moon. Micro-cap stocks, as the name suggests, are tiny companies - they typically have little financial backstop, and often pin their hopes on a single product or service. Single-digit annual gains and a 2% dividend yield? No … here and there, investors should try to generate bigger returns from more explosive small- and even micro-cap stocks. Those large caps can offer somewhat modest returns. But there’s a reason most financial advisers say to have at least a small allocation to speculative investments.